Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach
Abstract Drug repositioning research using transcriptome data has recently attracted attention. In this study, we attempted to identify new target proteins of the urotensin-II receptor antagonist, KR-37524 (4-(3-bromo-4-(piperidin-4-yloxy)benzyl)-N-(3-(dimethylamino)phenyl)piperazine-1-carboxamide d...
Guardado en:
Autores principales: | Gyutae Lim, Chae Jo Lim, Jeong Hyun Lee, Byung Ho Lee, Jae Yong Ryu, Kwang-Seok Oh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e79377f13c34e84b8825e436aafd9b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
por: N Kheiripour, et al.
Publicado: (2019) -
Effects of in vivo repositioning of slim modiolar electrodes on electrical thresholds and speech perception
por: Sang-Yeon Lee, et al.
Publicado: (2021) -
Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance.
por: María E Sáez, et al.
Publicado: (2011) -
Evaluation of connectivity map shows limited reproducibility in drug repositioning
por: Nathaniel Lim, et al.
Publicado: (2021) -
Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity.
por: Laurence Desrues, et al.
Publicado: (2012)